LINC01354 Promotes Osteosarcoma Cell Invasion by Up-regulating Integrin β1

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Long noncoding RNAs (lncRNAs) are implicated in cancer development, including osteosarcoma (OS).
• The specific role and mechanism of lncRNAs in osteosarcoma metastasis are not fully understood.
• Investigating novel lncRNAs like LINC01354 is crucial for understanding OS progression.

Purpose of the Study:

• To investigate the clinical significance of LINC01354 in osteosarcoma.
• To elucidate the biological function and molecular mechanism of LINC01354 in osteosarcoma metastasis.
• To explore LINC01354 as a potential therapeutic target for OS.

Main Methods:

• Quantitative real-time PCR and Western blot to assess LINC01354 and integrin β1 expression in OS tissues, serum, and cell lines.
• In vitro assays (Transwell, EMT markers) to evaluate the functional impact of LINC01354.
• In vivo xenograft mouse models to confirm LINC01354's role in OS metastasis.
• Integrin β1 blocking experiments to validate the molecular mechanism.

Main Results:

• LINC01354 was significantly overexpressed in osteosarcoma tissues, serum, and cells.
• LINC01354 overexpression enhanced OS cell invasion, epithelial-mesenchymal transition (EMT), and integrin β1 expression.
• Knockdown of LINC01354 inhibited OS cell invasion, EMT, and integrin β1 expression, while integrin β1 blockage reversed these effects.
• LINC01354 promoted osteosarcoma metastasis in vivo.

Conclusions:

• LINC01354 promotes osteosarcoma cell invasion and metastasis by upregulating integrin β1.
• LINC01354 plays a critical role in the progression of osteosarcoma.
• LINC01354 represents a promising potential therapeutic target for osteosarcoma.